generics

Original Contribution

Toward Personalized DAPT: Is There an Inter-Manufacturer Difference in Generic Clopidogrel Response?

11/23/2022

Sylvie Hall, PharmD, MPH¹; Yuhe Xia, MS²; Hamza Ahmed, BA³;
Daniela Iskhakov, PA-C⁴; Frederick Feit, MD⁴; Carlos L. Alviar, MD⁴;
Jeffrey S. Berger, MD, MS⁴; Norma Keller, MD⁴; Sripal Bangalore, MD, MHA⁴

Sylvie Hall, PharmD, MPH1; Yuhe Xia,...

This quality-improvement project included 515 adult patients receiving clopidogrel for ACS or ischemic heart disease and referred for coronary angiography/percutaneous coronary intervention. The project was divided into 2 phases: (1)...

This quality-improvement project...

11/23/2022

Journal of Invasive Cardiology

Research Reports

Trend in TKI Use, Adherence, and Switching Patterns in Patients With CML: Before and After the Availability of Generic Imatinib

08/19/2020

&quot

Henry J Henk, PhD

Lena E Winestone, MD, MSHP

Jennifer J Wilkes, MD, MSCE

Pamela Morin, MBA

Shasank Chennupati, PharmD, MPH

David R Doody, MS

Eric J Chow, MD, MPH

Gary H Lyman, MD, MPH&quot

Abstract: The therapeutic landscape for chronic myeloid leukemia (CML) has evolved substantially over the past decade, most notably with the introduction of second- and third-generation tyrosine kinase inhibitors...

...

08/19/2020

Journal of Clinical Pathways